A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors
Abroad (travel likely)RecruitingPHASE1
Conditions
Tumor Associated Lymph Node T Cell · Advanced Solid Tumor · Immunotherapy · Serplulimab Injection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sun Yat-sen University Cancer Center, Guangzhou, Gaungdong, China
Contact: Principal Investigator (Xiaoshi Zhang, Professor)